One thing different about 4th quarter is that expectations are low compared to previous quarters where expectations were high. I expect a much better 2020 as states clarify CBD regulations ahead of the FDA enforcement discretion, allowing us to enter those markets with our top-selling consumables. Big year as this all plays out.